A serine/arginine-rich splicing factor 3 (SRSF3) (also known as SRp20) is a member of the SR protein family which comprises at least 12 evolutionarily conserved and structurally related RNA-binding proteins (SRSF1 to SRSF12) (24). Like other SR proteins, SRSF3 binds cis-acting RNA elements through an N-terminal RNA recognition motif (RRM), and a C-terminal region enriched in Arg-Ser dipeptides (RS domain) mediates interactions with other proteins for regulation of both constitutive and alternative splicing of pre-mRNA (7).
, and cell cycle regulation (16) . In addition, a short hairpin RNA-based screen of splicing regulators has uncovered a novel function of SRSF3 as a negative regulator of interleukin (IL)-1(28)Moreover,SRSF3 is overexpressed in human ovarian cancer, and its knockdown results in apoptosis of ovarian cancer cells (10) . These findings suggest that SRSF3 contributes to biological networks for cell fate.
The human SRSF3 gene is composed of 7 exons and 8 introns, and generates two mRNA isoforms through alternative splicing. SRSF3 exon 4 contains multiple premature stop codons (PTCs); therefore, a major SRSF3 mRNA isoform, which encodes a functional full-length SRSF3 protein (SRSF3-FL), excludes this exon 4. Alternative splicing of SRSF3 pre-mRNA produces another mRNA isoform consisting of entire 7 exons. This PTC-containing SRSF3 isoform (SRSF3-PTC) should be degraded through nonsense-mediated mRNA decay (NMD), a surveillance mechanism that decomposes PTC-containing mRNAs. However, this isoform is considered to contribute auto-regulation of its own mRNA expression in a cell cycle specific manner (12) . At the same time, it was reported that SRSF3-PTC mRNA was translatable into a truncated SRSF3 protein (SRSF3-TR) partially lacking RS domain in the murine B-cell lymphoma K46 cells (12) . However, the biological function of SRSF3-TR remains to be elucidated.
In this study, we showed that significant amounts of SRSF3-TR were translated from Ms. ID:C-00091-2013-R1 4 SRSF3-PTC mRNA in colon cancer cells exposed to an oxidant (sodium arsenite). Moreover, we suggest that SRSF-TR may function as a positive regulator of oxidative stress-stimulated production of IL-8 through regulating c-JUN expression. The present study may provide a new insight into the biological function of PTC-containing mRNAs of the SR protein family genes.
MATERIALS AND METHODS
Cell culture and subcellular fractionation. HCT 116 cells were cultured in McCoy's 5A medium (Gibco, Grand Island, NY) supplemented with 5% (vol/vol) heat-inactivated fetal bovine serum and antibiotics at 37°C in 5% CO2. After HCT116 cells were incubated in lysis buffer (10 mM Tris-HCl, pH 7.4; 100 mM NaCl; 2.5 mM MgCl2; 40 μg/ml digitonin) for 10 min, lysates were centrifuged at 2,060 g for 8 min at 4°C, and supernatants were collected as cytosolic extracts. The remaining pellets were washed twice with the lysis buffer and further lysed with RIPA buffer (10 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1 mM DTT; 0.1% SDS; 1% NP-40) containing a protease and phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). After centrifugation at 21,000 g for 10 min at 4°C, supernatants were collected as nuclear extracts. Cells lysed with RIPA buffer were used as whole-cell extracts (18) .
Plasmid construction. A cDNA library was prepared from HCT116 cells, and the human SRSF3 mRNAs (Ensembl Transcript ID: ENST00000373715 (SRSF3-FL) and ENST00000477442 (SRSF3-PTC)) were amplified by PCR using a primer set:
5'-AAAAAAGGATCCATGCATCGTGATTCCTGTCCATTG-3' (forward; BamHI site is underlined) and 5'-AAAAAAGATATCCTATTTCCTTTCATTTGACCTAGA-3' (reverse;
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EcoRV site is underlined). The amplified products were separated using a gel extraction kit (Qiagen, Hilden, Germany) and cloned into the mammalian expression vector pCMV-3Tag (Stratagene, La Jolla, CA). FLAG was appended to the NH2 termini of SRSF3. All constructs were confirmed to have the expected sequence by DNA sequencing. These plasmids were transfected using FuGENE HD (Promega, Madison, WI) according to the manufacturer's instructions. RNAi negative control (Invitrogen) was used as a control siRNA. HCT116 cells were transfected with 10 nM of one of these siRNAs using Lipofectamine RNAiMAX (Invitrogen).
Small interference RNAs (siRNAs)
.
Quantitative real-time reverse transcription-PCR (qPCR).
Total RNAs were extracted from HCT116 cells using an RNAiso plus (Takara, Otsu, Japan). One microgram of isolated RNA was reverse-transcribed using ReverTra Ace reverse transcriptase (TOYOBO, Osaka, Japan). SRSF3-FL, SRSF3-PTC, IL-8, IL-1β, IL-6, IFN-γ, and TNF-α mRNA levels were measured using SYBR green master mix and the 7500 real-time system (Applied Biosystems, Foster City, CA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA and 18S
were measured as internal controls for normalization. Using the ΔΔCt method, the data are presented as the fold change in gene expression relative to controls measured in the untreated or control siRNA-treated cells. The sequences of primer sets used are shown in Table 1 .
Inhibition of NMD activity and chemiluminescence-based NMD assay. To inhibit the NMD system, HCT116 cells were treated with 50 or 100 g/ml cycloheximide for 6 h or with 10 nM UPF1 siRNA for 48 h. Plasmids containing pCI-neo -globin-wt (WT), pCI-neo -globin-NS39 (NS39), and pCI-neo-firefly were kindly provided by Dr. Kulozik and used for chemiluminescence-based NMD assay (3). Twenty-four hours after pretreatment of HCT116 cells with control or SRSF-PTC siRNA, they were co-transfected with pCI-neo-firefly and WT or NS39, and then incubated for another 24 h. These cells were left untreated or treated with 100 M arsenite for the indicated times. Cell lysates were prepared, and renilla and firefly luciferase activities were measured with dual luciferase assay system (Promega) according to the manufacturer's protocol. The transfection efficacy was assessed by firefly luciferase activity.
Measurement of IL-8 concentration in the culture medium. After treatment of HCT116
cells with control or SRSF3-PTC siRNA for 24 h, they were exposed to 100 M arsenite for the indicated times, and supernatants were collected. Cell debris were removed by centrifugation at 10,000 g for 5 min at 4°C, and the resultant supernatants were subjected to ELISA measurement of IL-8 using a commercially available ELISA kit (Biolegend, San Diego, CA) according to the protocols provided by the manufacturer.
Western blotting. Whole-cell lysates were prepared in RIPA buffer (10 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1 mM DTT; 0.1% SDS; 1% NP-40) containing a protease and phosphatase inhibitor cocktail (Sigma-Aldrich). The extracted proteins were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (BioRad, Hercules, CA).
After blocking with 5% non-fat dry milk, the membranes were incubated overnight at 4°C with a mouse monoclonal anti-SRSF3 (1:1000 dilution; Sigma-Aldrich), anti-phospho-JNK Immunohistochemistry. HCT116 cells growing on a multichamber culture slide (Matsunami Glass Ind., Osaka, Japan) were rinsed briefly in phosphate-buffered saline (PBS) and then fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. The fixed cells were permeabilized in PBS containing 0.1% Triton X-100 for 10 min. After blocking with 4% Block Ace (Snow Brand Milk Products Co., Tokyo, Japan) at room temperature for 1 h, slides were incubated overnight at 4 o C with a mouse anti-FLAG (1:2000 dilution, Sigma-Aldrich) and a rabbit anti-TIAR (1:1600, Cell Signaling Tech.) antibodies in PBS containing 1% Block ACE and 0.1% TritonX-100. After washing, the slides were treated with a 1:1000 dilution of Alexa Fluor 488-conjugated anti-mouse IgG (Invitrogen) and a 1:1000 dilution of Alexa Fluor 555-conjugated anti-rabbit IgG. Nuclei were counterstained with TO-PRO-3 (Molecular Probes, Eugene, OR). After washing, the slides were mounted in Vectashield mounting medium (Vector Labo., Burlingame, CA) and examined by a confocal laser-scanning microscopy (FluoView FV1000; Olympus, Tokyo, Japan). Signal intensities of anti-c-JUN reactive bands were quantified using Image J software (http://www.rsb.info.nih.gov/ij/).
Promoter activity assay. The 5′ flank of the human IL-8 gene was cloned into the pGL3-basic luciferase reporter vector (Promega). In brief, the first PCR was performed using human genomic DNA as a template. The IL-8 proximal promoter region (from -652 to +46 bp) was amplified using the following primer set: 5'-TGAGTCAGTGACTCAGTGAGTCAGTGACTCAGTGAGTCAGTGACTCAG-3' was subcloned into the pGL3-minP. pGL3-minP was used as a negative promoter activity. HCT116 cells (2.0 x 10 4 cells) were cultured on 24-well plates, and then pGL-3 luciferase constructs (100 ng) were co-transfected with pRL-CMV vector (50 ng) using FuGENE HD (Promega). Twenty-four hours after the transfection, cells were harvested, and the firefly and renilla luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega).
Electrophoretic mobility shift assay (EMSA). Nuclear proteins were prepared from HCT116 cells as previously described (17) . A double-stranded oligonucleotide for the AP1 consensus binding site (-132 to -108 bp, GTGTGATGACTCAGGTTTGCCCTGA ) was The nuclear chromatin DNA from HCT116 cells (input) was used as a positive control for PCR.
RESULTS

Production of SRSF3-PTC mRNA isoform after exposure to sodium arsenite. SRSF3
generates two mRNA isoforms through alternative splicing, a major isoform (we describe here as SRSF3-FL) and a minor isoform (SRSF3-PTC) (Fig. 1A) . When HCT116 cells were exposed to 100 M arsenite or 500 M hydrogen peroxide (H2O2) for 6 h, they significantly increased SRSF3-PTC mRNA levels without changing SRSF3-FL mRNA levels (Fig. 1B) .
Pretreatment with an antioxidant N-acetyl-cysteine pretreatment (NAC, 10 mM) almost completely blocked both arsenite-and H2O2-stimulated SRSF3-PTC mRNA expression, suggesting that oxidative stress stimulates production of SRSF3-PTC mRNA isoform (Fig.   1B ). After treatment of HCT116 cells with 100 M sodium arsenite, SRSF3-PTC mRNA levels were increased with a peak at 3 h, and remained to be elevated for at least 12 h without changing SRSF3-FL mRNA levels ( Fig. 2A) . The arsenite-stimulated production of SRSF3-PTC mRNA through alternative splicing was also detectable by RT-PCR using the primer set designed to amplify the exons 3-5 ( Treatment with SRSF3-PTC siRNA specifically targeting SRSF3 exon 4 completely blocked the arsenite-induced appearance of the immunoreactive protein band (Fig. 2D) , indicating that the 14 kDa protein was likely to be SRSF3-TR.
NMD-mediated degradation of SRSF3-PTC mRNA. mRNAs containing PTCs that are located more than 50 nucleotides upstream of the final exon-exon junction are considered to be targets for NMD (26). To examine whether SRSF3-PTC mRNA is actually regulated by NMD, we first disrupted NMD by knockdown of UPF1, which is an essential factor of NMD pathway (29) . Reduction of UPF1 after treatment with UPF1 siRNA for 48 h ( degrades PTC-containing mRNAs mainly in the cytoplasm. Nuclear and cytoplasmic fractions were prepared before (0) or 3 and 6 h after treatment with arsenite, and the purity of each fraction was confirmed by RT-PCR using the primer set for GAPDH pre-mRNA ( Fig.   4A ). In cytoplasmic fractions, an exon 4-containing transcript (SRSF3-PTC) appeared 3 h after exposure to arsenite, and its levels time-dependently increased (Fig. 4A ). In nuclear fractions, SRSF3-PTC mRNA was present before arsenite treatment, and its levels were not changed after exposure to arsenite (Fig. 4A) . The time-dependent changes in subcellular distribution of SRSF3-PTC mRNA were quantified by qPCR (Fig. 4B) . qPCR demonstrated that treatment with arsenite increased SRSF3 PTC mRNA levels preferentially in the cytoplasm (20-fold increase), compared with those in the nucleus (less than 2-fold increase) ( Fig. 4B and C) . These results suggested that in the presence of arsenite, SRSF3-PTC mRNA appeared to escape from degradation through the NMD system, and significant amounts of SRSF3-PTC mRNA were accumulated in the cytoplasm. As a consequence, SRSF3-TR could be transiently translated from SRSF3-PTC mRNA under oxidative stress.
Phosphorylation and subcellular localization of SRSF3-TR. Phosphorylation of RS domain determines the subcellular localization of individual SR proteins (5, 21). It has been
shown that functional SRSF3-FL localizes in the nuclear speckles (4, 23) . We next examined phosphorylation and subcellular localization of SRSF3-TR partially lacking RS domain. Since the anti-SRSF3 antibody used was raised against the N-terminus of SRSF3, it could not distinguish between SRSF3-TR and SRSF3-FL. We therefore transfected plasmids encoding
FLAG-tagged-SRSF3-FL or -PTC and assessed phosphorylation of SRSF3-TR and SRSF3-FL
by Western blotting using the anti-SRSF3 and an anti-FLAG antibodies ( To examine the subcellular localization of SRSF3-FL and SRSF3-TR, we performed double-immunofluorostaining with an antibody to FLAG and an antibody to a stress granule-associated TIAR protein using FLAG-SRSF3-FL-or -TR-overexpressing HCT116 cells. Confocal laser-scanning microscopy showed that FLAG-SRSF3-FL was localized in nuclei ( Fig. 6e) , and a part of FLAG-SRSF3-FL was translocated to stress granules that appeared in the cytoplasm 6 h after exposure to arsenite (Fig. 6h') . In contrast, FLAG-SRSF3-TR was diffusely distributed in both the nucleus and the cytoplasm (Fig. 6i) .
At the same time, overexpression of FLAG-SRSF3-TR itself induced formation of stress granules in unstressed HCT116 cells (Fig. 6j) , and a part of FLAG-SRSF3-TR was associated with them ( Fig. 6l) . After arsenite treatment, SRSF3-TR still remained in both stress granules and nucleus (Fig. 6l') .
Effect of SRSF3-TR on arsenite-stimulated IL-8 production.
It has recently been shown that SRSF3 acts as a negative regulator of inflammation (28) . We also examined whether that arsenite-stimulated elevation of IL-8 mRNA levels was significantly attenuated in SRSF3-PTC siRNA-treated cells, compared with control siRNA-treated cells (Fig. 7A) .
Consequently, SRSF3-PTC siRNA significantly decreased arsenite-stimulated IL-8 release (Fig. 7B) .
The gene transcription (11) . As shown in Fig. 9A and B, the induction of c-JUN protein was significantly reduced 3, 6, and 9 h after exposure to arsenite in SRSF3-PTC siRNA-treated cells, compared with that in control siRNA-treated cells. There were no differences in expression and phosphorylation of p38 MAPK, ERK, or c-Fos between SRSF3-PTC and control siRNA-treated cells (Fig. 9A) . We also investigated the possibility that changes in NFB activation were involved in the attenuation of the IL-8 gene transcription in SRSF3-PTC siRNA-treated cells. We compared phosphorylation of an essential factor of NFκB (p65), and confirmed that SRSF3-PTC knockdown did not change p65 phosphorylation after exposure to arsenite (Fig. 9A) . These results suggested that the reduction of c-JUN protein might be responsible for the down-regulation of arsenite-stimulated IL-8 gene transcription in SRSF3-PTC siRNA-treated cells.
Reduction of c-JUN binding to IL-8 promoter in SRSF3-PTC siRNA-treated cells.
To determine whether the AP-1 consensus sequence (TGACTCA) located at -126 and -120 bp in the 5′-flanking region was able to interact with c-JUN, we synthesized a 25-bp double-stranded oligonucleotide (−132 to −108 bp;GTGTGATGACTCAGGTTTGCCCTGA) and used it as a probe for electrophoretic mobility shift assay. As shown in Fig. 10A , arsenite stress for 3 h strongly generated a complex that was weakly induced in cell lysates from cells not treated with arsenite, and SRSF3-PTC siRNA treatment reduced this arsenite-induced complex. Unlabeled self-oligonucleotide, but not the mutated AP-1 oligonucleotide (GTGTGATATCTCAGGTTTGCCCTGA), competed for formation of this complex.
Moreover, preincubation with an anti-cJUN antibody, but not rabbit IgG, supershifted this band and produced a more slowly migrated band (Fig. 10A) . Together, these results indicate Jumaa and Nielsen reported that SRSF1 (also known as ASF/SF2) and SRSF2 (SC35)
were involved in the exclusion of SRSF3 exon 4 (13, 14) . The inclusion of exon 4 to mature SRSF3 mRNA was reported to occur under serum starvation (12) , and the biological significance of exon 4-inclusion is considered to be an auto-regulatory feedback loop by SRSF3 itself (13) . Moreover, because of multiple PTCs in the exon 4, a recent study (19) together with our findings have revealed that exon 4-including SRSF3-PTC mRNA is a target for NMD. To avoid production of the C-terminally truncated proteins which have potential dominant-negative or gain-of-function, PTC-containing mRNAs are expected to be degraded by NMD. However, several lines of evidence have shown that NMD activity is often inhibited by stresses, such as hypoxia, amino acid starvation, and generation of reactive oxygen species (8, 27, 35) . Consistent with those reports, our results also suggest that the cytoplasmic accumulation of SRSF3-PTC mRNA may, at least in part, result from inhibition of NMD under arsenite-induced oxidative stress. In addition, expression of PTC-containing mRNA isoforms of other SR protein genes (SRSF6, SRSF7 and SRSF9) were also up-regulated after exposure to arsenite (data not shown), suggesting that arsenite stress may extensively modify AS-NMD events. Arsenite stress may also change alternative splicing pattern to preferentially Fig. 4B and C) , while it did not change the major isoform (SRSF3-FL mRNA) levels ( Fig. 2A) . Arsenite treatment apparently stabilized SRSF3-PTC mRNA (Fig. 3E) . These results suggest that regulation of mRNA stability may play an important role in the arsenite-induced accumulation of truncated SRFS3 protein.
Overexpression of SRSF3-TR alone could induce stress granule formation. Interestingly, a part of SRSF3-TR was co-localized with a stress granule marker TIAR. It was reported that HCT116 cells were transfected with a plasmid encoding Flag-tagged SRSF3-FL ,SRSF3-TR, or mock. Before (control) or after exposure to 100 M arsenite for 6 h, they were subjected to double-immunofluorescence staining using antibodies against FLAG (green) and TIAR (red), and then their nuclear were stained with TO-PRO3 (blue). Subcellular localization of FLAG-SRSF3-FL and FLAG-SRSF3-TR were visualized by a confocal laser-scanning microscopy (FluoView FV1000; Olympus). Representative data are shown from three independent experiments. SRSF3-PTC siRNA, they were exposed to 100 M arsenite for the indicated times.
Whole-cell lysates were prepared from them and subjected to Western blotting using the Values are means ± SD, n=4. *Significantly different by ANOVA and Scheffe's test (P < 0.05).
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Representative data are shown from three independent experiments. (D) After treatment of HCT116 cells with control or SRSF3-PTC siRNA for 24 h, they were transfected with a pGL3-AP1 or pGL3-minP (minP) reporter vector, and then incubated for another 24 h. These cells were left untreated or treated with 100 M arsenite for 6 h, and then luciferase activity was measured using the Dual-Luciferase Reporter Assay System. Data are shown as arsenite-stimulated luciferase activity relative to that in untreated cells. 
